期刊文献+

外周血多潜能间充质基质细胞在骨组织工程中的应用进展 被引量:3

Application of peripheral blood-derived multipotent mesenchymal stromal cells in bone tissue engineering
下载PDF
导出
摘要 外周血来源的多潜能间充质基质细胞数量较少,它们表达骨髓来源的多潜能间充质基质细胞的大部分表面标记物,具有多样复杂的基因表达特征。虽然它们的起源和生理病理机制不清,但成人外周血间充质基质细胞的存在使其在组织工程领域备受争议和关注。本文就外周血来源的多潜能间充质基质细胞在骨组织工程中的应用作一综述。 Peripheral blood-derived multipotent mesenchymal stromal cells circulate in low number.They share most of the surface markers with bone marrow-derived multipotent mesenchymal stromal cells,possess diverse and complicated gene expression characteristics.Although their origin and physio-pathological function are still unclear,their presence in the adult peripheral blood might relate to controversial subjects in the field of tissue engineering.In this review,current studies about peripheral blood-derived multipotent mesenchymal stromal cells are summarized,and its application in bone tissue engineering is discussed.
作者 韩雪 刘洪臣
出处 《国际口腔医学杂志》 CAS 2011年第1期71-74,共4页 International Journal of Stomatology
基金 国家自然科学基金资助项目(30973354)
关键词 外周血 成纤维样集落形成单位 多潜能间充质基质细胞 骨组织工程 peripheral blood colony-forming unit fibroblastic multipotent mesenchymal stromal cell bone tissue engineering
  • 相关文献

参考文献31

  • 1Wan C, He Q, Li G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regenera- tion in rabbit ulna critical-sized bone defect model[J]. J Orthop Res, 2006, 24(4):610-618.
  • 2Huss R, Lange C, Weissinger EM, et aL Evidence of pe- ripheral blood-derived, plastic-adherent CD34 (-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics[J]. Stein Cells, 2000, 18 (4) : 252-260.
  • 3Kuznctsov SA, Mankani MH, Gronthos S, et al. Circula-ting skeletal stem cells[J]. J CeU Biol, 2001, 153 (5): 1133-1140.
  • 4Koomer J, Nesic D, Romero JD, et al. Equine peripher- al blood-derived progenitors in comparison to bone mar- row-derived mesenehymal stem ceLls[J]. Stem Cells, 2006, 24(6) : 1613-1619.
  • 5Giovannini S, Brehm W, Mainil-Varlet P, et al. Multi- lineage differentiation potential of equine blood-derived fibroblast-like cells[J]. Differentiation, 2008, 76(2):118- 129.
  • 6Tondreau T, Meuleman N, Delforge A, et al. Mesenehy- real stem cells derived from CD133-positive ceils in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity[J]. Stem Cells, 2005, 23 (8) : 1105-1112.
  • 7曹聪,董英海,董宇启,路丽明,崔磊,刘伟,曹谊林.人血源性间充质干细胞培养与体外成骨研究[J].中国修复重建外科杂志,2005,19(8):642-647. 被引量:15
  • 8Moosmann S, Hutter J, Moser C, et al. Milieu-adopted in vitro and in vivo differentiation of mesenchymal tis- sues derived from different adult human CD34-negative progenitor eeU clones[J]. Cells Tissues Organs, 2005, 179 (3) : 91-101.
  • 9Kassis I, Zangi L, Rivkin R, et al. Isolation of mesen- chymal stem cells from G-CSF--mobilized human periphe- ral blood using fibrin microbeads[J]. Bone Marrow Tran- splant, 2006, 37 (10) : 967-976.
  • 10Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal in- dividuals[J]. Axthritis Res, 2000, 2(6):477--488.

二级参考文献85

共引文献48

同被引文献34

  • 1王东胜,路正刚.种植体骨界面组织形态学研究方法探讨[J].中华老年口腔医学杂志,2005,3(3):142-144. 被引量:12
  • 2黄若昆,林月秋.可注射性骨组织工程载体研究进展[J].中国矫形外科杂志,2007,15(9):681-683. 被引量:5
  • 3Akimoto K, Becker W, Persson R, et al. Evaluation of tita- nium implants placed into simulated extraction sockets., a study in dogs[J]. The International journal of oral & maxillo- facial implants, 1999, 14(3) : 351-360.
  • 4Liu HY, Liu X, Zhang LP, et al. Improvement on the per- formance of bone regeneration of calcium sulfate hemihydrate by adding mineralized collagen [J]. Tissue engineering Part A, 2010, 16(6):2075-2084.
  • 5Seta N, Kuwana M. Derivation of multipotent progenitors from human circulating CD14+ monocytes[J]. Experimental hematology, 2010, 38(7): 557-563.
  • 6Yoshikawa H, Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics[J]. J Artif Organs, 2005, 8 (3):131-136.
  • 7Sidqui M, CoUin P, Vitte C, et al. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate[J]. Biomaterials, 1995, 16(17):1327-1332.
  • 8Nilsson M, Wang JS, Wielanek L, et al. Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute[J]. The Journal of bone and joint surgery British volume, 2004, 86(1): 120-125.
  • 9Winn SR, Hollinger JO. An osteogenic cell culture system to evaluate the cytocompatibility of Osteoset, a calcium sulfate bone void filler[J]. Biomaterials, 2000, 21(23):2413-2425.
  • 10Walsh WR, Morberg P, Yu Y, et al. Response of a calcium sulfate bone graft substitute in a confined cancellous defect[J]. Clinical orthopaedics and related research, 2003 (406):228- 236.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部